Clark Jeffrey A, McKeirnan Kimberly C, Gates Brian J
Home Healthc Now. 2025;43(5):294-305. doi: 10.1097/NHH.0000000000001377. Epub 2025 Sep 8.
Medication reconciliation was adopted as a National Patient Safety Goal by the Joint Commission in 2005 and is now standard practice across care settings. More recently, the concept of medication optimization has gained attention, recognizing that safe medication use requires more than reconciliation alone. Home healthcare (HHC) is one setting with a critical need for medication optimization. This work describes a pharmacist-led interdisciplinary team (IDT) effort to reduce hospitalization rates at Providence VNA Home Health by improving medication reconciliation, evaluation, and prescriber communication. The IDT developed a tool and a 1-hour training with operational definitions and scenarios for reconciliation and documentation, along with a separate training focused on medication evaluation. To assess training effectiveness, the primary outcome was to reduce 30-day hospitalizations among high-risk heart failure patients to below 12%. This outcome was met and sustained for 8 weeks post-implementation. A secondary goal-reducing 30-day rehospitalizations per Strategic Healthcare Programs (SHP)-was also met and sustained from April to December 2020. This quality improvement project demonstrated that enhancing medication reconciliation and evaluation in high-risk patients reduces hospitalizations. Reconciliation may be especially important in patients with two or more self-reported unreconciled medications in the EHR, which may signal suboptimal medication evaluation. Addressing the challenges HHC clinicians face in optimizing medications and reinforcing best practices can improve outcomes. Pharmacists play a key role in interdisciplinary teams in HHC, given the complexity of medications and their impact on quality measures.
2005年,药物重整被美国医疗机构评审联合委员会采纳为一项全国患者安全目标,如今已成为各医疗机构的标准做法。最近,药物优化的概念受到关注,因为人们认识到安全用药不仅仅需要药物重整。家庭医疗保健(HHC)是一个急需药物优化的领域。这项工作描述了由药剂师领导的跨学科团队(IDT)为普罗维登斯VNA家庭健康中心降低住院率所做的努力,该努力通过改进药物重整、评估和开处方者沟通来实现。IDT开发了一种工具以及为期1小时的培训,其中包含药物重整和记录的操作定义及场景,还有一项专门针对药物评估的培训。为评估培训效果,主要结果是将高危心力衰竭患者的30天住院率降低至12%以下。这一结果得以实现,并在实施后持续了8周。第二个目标——按照战略医疗保健计划(SHP)降低30天再住院率——也在2020年4月至12月期间得以实现并持续。这个质量改进项目表明,加强高危患者的药物重整和评估可降低住院率。在电子健康记录(EHR)中有两种或更多自我报告的未重整药物的患者中,药物重整可能尤为重要,这可能表明药物评估未达到最佳效果。应对HHC临床医生在优化用药方面面临的挑战并强化最佳实践可以改善治疗结果。鉴于药物的复杂性及其对质量指标的影响,药剂师在HHC的跨学科团队中发挥着关键作用。